Revealing therapeutic leads
"The precision of our metagenomic analysis reveals a world of untapped opportunity."
Associate Professor Lutz Krause Chief Scientific Officer
Our Therapeutic programs
Microba has two major therapeutic programs underway using insights from our leading analysis platform and our unique approach to genome-directed isolation.
|Inflammatory Bowel Disease||Pre-clinical||Phase 1||-|
|Immuno-Oncology Neoadjuvant Therapy||Discovery||Pre-clinical||-|